89bio Reports Cash Positions As Of Dec. 31, 2021 $150.7M
Fourth Quarter and Full Year 2021 Financial Results
Cash Position. As of December 31, 2021, 89bio had cash, cash equivalents, and short-term investments totaling $150.7 million compared